Centre for Cellular and Molecular Platforms (C-CAMP), a Bengaluru-based technology and innovation hub, and the California Institute for Quantitative Biosciences (QB3) have signed a Letter of Intent (LoI) to create the US-Indo Life Science Sister Innovation Hub.

QB3 is a San Francisco Bay-area based non-profit research and technology commercialisation institute spanning three University of California campuses.

C-CAMP has worked extensively to establish a strong life science innovation and entrepreneurship ecosystem in and around Bengaluru with support from DBT and BIRAC. The LoI was signed during Prime Minister Narendra Modi’s visit to the Bay Area last month.

This partnership with QB3 provides an opportunity for C-CAMP to make stronger ties with the San Francisco Bay area cluster, one of the leading innovation ecosystems in the world.

Taslimarif Saiyed, Director and COO, C-CAMP, said, “The Innovation hub is aimed at fostering links between both these exciting innovative hubs and enhancing science based entrepreneurship, research, academia and businesses.”

Through this innovation hub, both the organizations plan to promote collaborations in scientific research, encourage co-development of innovation led products and push these technologies towards commercialization.

Innovation-based start-ups will be nurtured and accelerated through incubation and funding opportunities by leveraging the existing entrepreneurial ecosystem in both countries, Saiyed said.